
BRD32048
CAS No. 433694-46-3
BRD32048( BRD-32048 | BRD 32048 )
Catalog No. M27757 CAS No. 433694-46-3
BRD32048 is a top candidate ETV1 perturbagen. BRD32048 inhibits p300-dependent acetylation of ETV1, thereby promoting its degradation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 155 | Get Quote |
![]() ![]() |
10MG | 259 | Get Quote |
![]() ![]() |
25MG | 484 | Get Quote |
![]() ![]() |
50MG | 699 | Get Quote |
![]() ![]() |
100MG | 981 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBRD32048
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRD32048 is a top candidate ETV1 perturbagen. BRD32048 inhibits p300-dependent acetylation of ETV1, thereby promoting its degradation.
-
DescriptionBRD32048 is a top candidate ETV1 perturbagen. BRD32048 inhibits p300-dependent acetylation of ETV1, thereby promoting its degradation.
-
In Vitro——
-
In Vivo——
-
SynonymsBRD-32048 | BRD 32048
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorTEAD,YAP1/TAZ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number433694-46-3
-
Formula Weight314.393
-
Molecular FormulaC16H22N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (397.60 mM)
-
SMILESCOc1ccc(cc1)\N=c1/nc(CN2CCCCC2)nc(N)[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ayumi Kaneda, et al. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. Am J Cancer Res. 2020 Dec 1;10(12):4399-4415.
molnova catalog



related products
-
VAL-083
VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.
-
Actinomycin D
A chemotherapy agent that has the ability to inhibit transcription.
-
Syk Inhibitor II
Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM).